Jyothy Labs to Pursue Legal Action Against Henkel Over Pril & Fa Brand Exit
Jyothy Labs Limited has decided to pursue legal remedies against Henkel AG & Co. KGaA to enforce contractual rights under the License Agreements for Pril and Fa brands, originally executed on May 31, 2011. The Board of Directors met on June 15, 2026, following Henkel's non-renewal of the brands, and concluded that legal action is necessary to uphold the agreed exit and transition mechanism.

*this image is generated using AI for illustrative purposes only.
Jyothy Labs Limited has decided to pursue legal remedies against Henkel AG & Co. KGaA to assert its contractual rights concerning the exit and transition mechanism under the License Agreements and Technology License Agreements for the Pril and Fa brands. This decision follows the non-renewal of these brands by Henkel, as previously intimated on May 9, 2026. The company's Board of Directors met on June 15, 2026, to evaluate available options and concluded that legal action is necessary to uphold the terms of the agreements executed on May 31, 2011.
Agreement Details
The License Agreements and Technology License Agreements involve Erstwhile Henkel India Limited, which has since amalgamated with Jyothy Labs Limited, and Henkel AG & Co. KGaA. These agreements cover the manufacturing, distribution, marketing, and sale of products under the Pril and Fa brands. The key details of the agreement are outlined below:
| Sr. No | Particulars | Details |
|---|---|---|
| A | Name of parties to the Agreement | Erstwhile Henkel India Limited (since amalgamated with Jyothy Labs Limited) and Henkel AG & Co. KGaA |
| B | Nature of the Agreement | License Agreements and Technology License Agreements for manufacturing, distribution, marketing and sale under Pril and Fa brands |
| C | Date of execution of the Agreement | May 31, 2011 |
| D | Details of termination and impact | Subsequent to discussions and communication from Henkel, the Company has evaluated all available options and concluded to pursue appropriate legal remedies |
Regulatory Disclosure
The disclosure was submitted to BSE Limited and the National Stock Exchange of India Limited under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Shreyas Parag Trivedi, Head – Legal & Company Secretary, signed the disclosure on behalf of the company. Jyothy Labs stated that it will keep the stock exchanges informed of any further material developments.
Historical Stock Returns for Jyothy Laboratories
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.14% | +2.63% | -6.65% | -27.97% | -38.52% | +29.60% |
How will the potential loss of the Pril and Fa brands impact Jyothy Labs' revenue projections for the upcoming fiscal year?
What is the estimated timeline for the legal proceedings, and how might prolonged litigation affect the company's operational focus?
Does Jyothy Labs have a contingency plan to replace the manufacturing capacity currently utilized for these licensed brands?


































